🇺🇸 FDA
Patent

US 11014983

Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies

granted A61KA61K39/39541A61P

Quick answer

US patent 11014983 (Anti-Tim-3 antibodies, compositions comprising anti-Tim-3 antibodies and methods of making and using anti-Tim-3 antibodies) held by Sutro Biopharma, Inc. expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sutro Biopharma, Inc.
Grant date
Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K39/39541, A61P, A61P35/00